CLEC7A
C-type lectin domain family 7 member A
Also known as: CD369, CLC7A_HUMAN, CLECSF12, DECTIN-1, hDectin-1, SCARE2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BXN2
- Gene
- CLEC7A
- Ensembl
- ENSG00000172243
- Chromosome
- 12
- Canonical length
- 247 aa
- Protein class
- CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. The encoded glycoprotein is a small type II membrane receptor with an extracellular C-type lectin-like domain fold and a cytoplasmic domain with an immunoreceptor tyrosine-based activation motif. It functions as a pattern-recognition receptor that recognizes a variety of beta-1,3-linked and beta-1,6-linked glucans from fungi and plants, and in this way plays a role in innate immune response. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. This gene is closely linked to other CTL/CTLD superfamily members on chromosome 12p13 in the natural killer gene complex region. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
247 residues, UniProt reviewed canonical sequence.
>Q9BXN2|CLEC7A
1 MEYHPDLENL DEDGYTQLHF DSQSNTRIAV VSEKGSCAAS PPWRLIAVIL GILCLVILVI
61 AVVLGTMAIW RSNSGSNTLE NGYFLSRNKE NHSQPTQSSL EDSVTPTKAV KTTGVLSSPC
121 PPNWIIYEKS CYLFSMSLNS WDGSKRQCWQ LGSNLLKIDS SNELGFIVKQ VSSQPDNSFW
181 IGLSRPQTEV PWLWEDGSTF SSNLFQIRTT ATQENPSPNC VWIHVSVIYD QLCSVPSYSI
241 CEKKFSMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CLEC7A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 79 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 79 nTPM
- appendix: 42 nTPM
- spleen: 32 nTPM
- lung: 28 nTPM
- lymph node: 13 nTPM
- tonsil: 11 nTPM
Single-cell type
- neutrophils: 664 nCPM
- kupffer cells: 638 nCPM
- monocytes: 474 nCPM
- cdc: 387 nCPM
- macrophages: 305 nCPM
- microglia: 221 nCPM
Immune cell
- neutrophil: 252 nTPM
- non-classical monocyte: 149 nTPM
- intermediate monocyte: 137 nTPM
- classical monocyte: 123 nTPM
- myeloid DC: 61 nTPM
- total PBMC: 40 nTPM
Brain region
- white matter: 16 nTPM
- medulla oblongata: 13 nTPM
- thalamus: 11 nTPM
- spinal cord: 11 nTPM
- pons: 10 nTPM
- hypothalamus: 9.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CLEC7A.
Disease | AllUniProt
Conditions CLEC7A is implicated in, by any mechanism.
- Candidiasis, familial, 4 (CANDF4) MIM:613108
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.88
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.12
- DepMap mean gene effect
- 0.22
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antifungal innate immune response
- apoptotic signaling pathway
- carbohydrate mediated signaling
- cell activation
- cell recognition
- cell surface pattern recognition receptor signaling pathway
- cellular response to molecule of fungal origin
- defense response to protozoan
- detection of fungus
- detection of yeast
- inflammatory response
- innate immune response
- phagocytosis, recognition
- positive regulation of calcineurin-NFAT signaling cascade
- positive regulation of calcium-mediated signaling
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of cell migration
- positive regulation of cell population proliferation
- positive regulation of cytokine production involved in immune response
- positive regulation of cytokine production involved in inflammatory response
- positive regulation of dendritic cell cytokine production
- positive regulation of gene expression
- positive regulation of interleukin-1 beta production
- positive regulation of interleukin-10 production
- positive regulation of interleukin-12 production
- positive regulation of interleukin-2 production
- positive regulation of interleukin-23 production
- positive regulation of interleukin-6 production
- positive regulation of interleukin-8 production
- positive regulation of MAPK cascade
- positive regulation of monocyte chemotactic protein-1 production
- positive regulation of nitric oxide biosynthetic process
- positive regulation of phagocytosis
- positive regulation of protein-containing complex assembly
- positive regulation of respiratory burst
- positive regulation of superoxide anion generation
- positive regulation of T-helper 17 type immune response
- positive regulation of tumor necrosis factor production
- positive regulation of type II interferon production
- positive regulation of wound healing
- regulation of calcineurin-NFAT signaling cascade
- regulation of canonical NF-kappaB signal transduction
- response to yeast
- stimulatory C-type lectin receptor signaling pathway
- T cell activation
- detection of molecule of fungal origin
- positive regulation of cell maturation
- positive regulation of lymphocyte activation
Molecular functions
- (1->3)-beta-D-glucan binding
- carbohydrate binding
- identical protein binding
- metal ion binding
- MHC protein binding
- pattern recognition receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CLEC7A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CLEC7A as an antibody target. Whether an autoantibody or antibody against CLEC7A could matter depends on whether native CLEC7A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CLEC7A is annotated at the cell surface, where native CLEC7A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CLEC7A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...